Aerobiotix Healthcare Air Quality Center of Excellence Designation

In collaboration with the International Respiratory Infections Society (IRIS), Aerobiotix is pleased to offer the Aerobiotix Healthcare Air Quality Center of Excellence Designation. This program recognizes healthcare facilities that maintain superior air quality standards in critical areas such as operating rooms. By partnering with IRIS and Aerobiotix, facilities showcase best practices, drive innovation, and enhance patient safety through effective air quality management.

A prestigious designation recognizing healthcare facilities that demonstrate exceptional commitment to maintaining superior air quality standards.

Responsibilities to Participate in the Aerobiotix Healthcare Air Quality Center of Excellence Program

  • Compliance with IRIS Program: Facilities must participate and comply with the IRIS Healthcare Air Quality Seal of RecognitionTM program outlined above
  • Clinical Research: Active participation in clinical research studies concerning air quality management
  • Clinical Data Sharing: Sharing relevant clinical data for research and analysis, adhering to privacy regulations
  • Implementation of Illuvia Sense Technology: Full implementation of Aerobiotix’s Illuvia Sense technology is required across participating health systems
All facilities must submit an application detailing their air quality management systems and compliance with required standards. Documentation and initial compliance checks will be reviewed via remote assessment, followed by an on-site audit. Based on the audit findings, facilities that meet or exceed the standards will be awarded the designation.

Demonstrate Your Commitment to Patient and Staff Safety

The Aerobiotix Healthcare Air Quality Center of Excellence program offers participating facilities the opportunity to demonstrate their commitment to patient and staff safety and innovation in healthcare. By actively participating in research, sharing clinical data, serving as a customer testimonial, and implementing the Aerobiotix Illuvia Sense technology, facilities can enhance air quality management practices and improve patient outcomes across the healthcare industry. Aerobiotix will renew the designation annually.

Program Benefits

  • Recognition as a leader in healthcare air quality management
  • Access to cutting-edge research and technology
  • Opportunities for collaboration and knowledge sharing with other top-performing healthcare facilities
  • Promotion of your facility’s status as a Center of Excellence on the Aerobiotix website, social media channels, and via press release
  • The Facility Seal recognizes your healthcare facility as a Center of Excellence. It may be displayed physically and used digitally on your healthcare system's website, social media, and other approved uses.

Eligibility

To earn the Aerobiotix Healthcare Air Quality Center of Excellence designation, facilities must first be general customers of Aerobiotix and participate in the IRIS Healthcare Air Quality Seal of Recognition program. This structured approach ensures that facilities are equipped with superior technology and committed to maintaining the highest air quality standards to prevent infections and prioritize patient and staff health.
POWERED BY

Dr. Hudson Garrett Jr.

Ph.D., MSN, MPH, MBA, FNP-BC, IP-BC, PLNC, AS-BC, VA-BC, HACP-IC, CMRP, LTC-CIP, CIC, CPPS, CCHR-S, CPHQ, CVAHP, CPXP, CDIPC, CPHRM, CHIPP-B, FACDONA, FAAPM, eFACHDM, FAOM, FRSPH, FNAP, FAHVAP, FACHE, FSHEA, FIDSA
Dr. Hudson Garrett is an Adjunct Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Louisville School of Medicine. He holds a Graduate Certificate in Infection Prevention and Infection Control from the University of South Florida. He has completed the Johns Hopkins Fellows Program in Hospital Epidemiology and Infection Control. He is a Distinguished Fellow and Practitioner in the National Academies of Practices. Dr. Garrett is a graduate of the Institute for Healthcare Improvement (IHI) 13-month Global Patient Safety Fellowship and is a graduate of the IHI Patient Safety Executive Development Program. Dr. Garrett was awarded the prestigious Fellowship Designation by the Society for Healthcare Epidemiology of America in recognition of his work in infectious diseases and infection prevention and control and the Fellow Designation by the Infectious Diseases Society of America. He holds Fellow’s Status and Board Certification in Healthcare Management from the American College of Healthcare Executives. He is an international Fellow in the Royal Society for Public Health and a Fellow in the Association of Healthcare Value Analysis Professionals. He is a frequent international lecturer in the areas of infectious diseases, healthcare-associated infections, vascular access, outbreak response and prevention, value analysis, and infection prevention and control. He holds Board Certifications in Infection Control, Vascular Access, Patient Safety, Healthcare Quality, Patient Experience, Antibiotic Stewardship, Prehospital Emergency Medicine, as a Designated Infection Control Officer, Healthcare Materials and Resource Management, Infection Control, Long-Term Care Infection Control, Critical Care Fundamentals, Healthcare Risk Management, Patient Safety, Patient Experience, Healthcare Value Analysis, Healthcare Management, and as a Director of Nursing in Post-Acute Care and Infection Prevention and Control.

He is the author of over 75 publications in peer-reviewed journals and has been involved in authoring national guidelines related to the specialty of vascular access and infection control. He is the current Chairperson for the newly formed Infection Prevention Taskforce for the Association of Perioperative Registered Nurses (AORN). Most recently, Dr. Garrett was honored with the Lifetime Achievement Award for his Volunteer Service and Leadership from the White House and President Joseph Biden. Dr. Garrett has a passion for “connecting the dots” across healthcare and bringing the various disciplines together to solve healthcare’s most complex challenges.

Ruth Carrico

Ph.D., DNP, FNP-C, CIC, FSHEA, FNAP, FAAN
Carrico & Ramirez, PLLC

Professor (gratis faculty), Division of Infectious Diseases

University of Louisville School of Medicine
Ruth Carrico PhD DNP APRN FNP-C CIC FSHEA FNAP FAAN is a senior consultant with Carrico & Ramirez, PLLC focused on infectious diseases, infection prevention and control, and vaccinology. She is also a Professor and Family Nurse Practitioner, gratis faculty, with the University of Louisville School Medicine, Division of Infectious Diseases. Dr. Carrico has received training specific for healthcare epidemiology at the Centers for Disease Control and Prevention (CDC) in conjunction with the Rollins School of Public Health at Emory University in Atlanta and the Society for Healthcare Epidemiology of America (SHEA).

Dr. Carrico served as editor for the APIC Text of Infection Control and Epidemiology from 2005-2012. In 2008, Dr. Carrico was appointed to the National Biosurveillance Subcommittee (NBS) Advisory Committee to the Director, Centers for Disease Control and Prevention, and in 2010 became a SHEA Fellow. In 2011, Dr. Carrico was appointed by Secretary Sebelius (Health and Human Services), to the Healthcare Infection Control Practices Advisory Committee (HICPAC). In 2012, she was presented with the Carole DeMille Achievement Award by APIC, an honor for an Infection Preventionist. In 2013, Dr. Carrico began serving the National Foundation for Infectious Diseases as the Board’s Nurse Planner and in 2014 became a Robert Wood Johnson Foundation Executive Nurse Fellow alumna. Dr. Carrico served as the 2016 president of the Certification Board of Infection Control and Epidemiology, Inc. (CBIC). In 2018, Dr. Carrico assumed the position of president of the Kentucky Nurses Association and in 2020 was recognized as a Distinguished Fellow in the National Academies of Practice. In October 2021, Dr. Carrico was inducted as a Fellow in the American Academy of Nursing, the highest honor in the nursing profession. Also in October 2021, Dr. Carrico assumed the role of Executive Director, then Senior Scientific Officer of the Norton Infectious Diseases Institute (NIDI) at Norton Healthcare, in Louisville Kentucky where she supported the scientific and educational activities of the four Centers (Clinical Research, Education & Training, Global Health, Public Health) within the Institute until early 2023. Following successful launch of the NIDI Centers, in 2023 Dr. Carrico moved to work as a consultant with healthcare organizations, public health and providers interested in addressing the challenges of infectious diseases prevention.

Dr. Julio Ramirez

MD, FACP
Chief Scientific Officer, Norton Infectious Diseases Institute,

Norton Healthcare, Louisville, Kentucky, USA.

Emeritus Professor of Medicne, Infectious Diseases,

University of Louisville, Louisville, Kentucky, USA
Julio Ramirez, MD, FACP is the Chief Scientific Officer at the Norton Infectious Diseases Institute at Norton Healthcare, in Louisville, Kentucky. He is also an Emeritus Professor of Medicine, Divison of Infectious Diseases at the University of Louisville, Louisville, Kentucky, and a Fellow of the American College of Physicians and the Infectious Diseases Society of America.

Dr. Ramirez received his medical degree and internal medicine training at La Plata National University School of Medical Science in Argentina. He trained in critical care medicine at the National Institute of Respiratory Diseases and Thoracic Surgery at the University of Chile; completed a residency in internal medicine at Lincoln Medical Center, New York Medical College; and a fellowship in infectious diseases at the University of Louisville School of Medicine. He is board-certified in internal medicine and holds subspecialty certification in infectious diseases.

Dr. Ramirez’s areas of clinical and translational research include community-acquired pneumonia (CAP), influenza, and emerging respiratory pathogens. Dr. Ramirez is directing the research activities of the Norton Infectious Diseases Institute. Dr. Ramirez’s research activities have received funding from the Centers for Disease Control and Prevention (CDC), the Department of Defense (DoD), and the National Institutes of Health (NIH). Dr. Ramirez has more than 300 peer-reviewed publications. He is also a reviewer for several journals including the New England Journal of Medicine and Annals of Internal Medicine. Dr. Ramirez is the Section Editor on pulmonary infections for the evidence-based clinical decision support UpToDate, and is the current president of the International Respiratory Infections Society.

Dr. Ramirez served as a member of the American Thoracic Society (ATS) committee for the development of national guidelines for the management of CAP, and more recently, on the ATS International Task Force guidelines for the management of COVID-19. He also served as a member of the Food and Drug Administration advisory committee for the approval of anti-infective drugs. Dr. Ramirez is the recipient of the 2013 European Respiratory Society Presidential Award in recognition of his outstanding contribution to research in the field of respiratory infections. Dr. Ramirez is the co-chair of the current ATS-IDSA national guidelines committee for the management of CAP.